Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Korsakoff Syndrome

ClinicalTrials.gov lists 4 trials for Korsakoff Syndrome or a narrower condition beneath it.

MeSH D020915 Nervous System Diseases C10 C23
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 1 Phase 4 Phase 4 1 Not applicable Not applicable 2 Phase 1 Phase 1 1 Phase 4 Phase 4 1 Not applicable Not applicable 2

Trials per phase

4 of the 4 trials are tagged with Korsakoff Syndrome itself; the rest are tagged with a narrower condition beneath it.

Get the Korsakoff Syndrome report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Korsakoff Syndrome trials start? (4)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1
  • Phase 4
  • Not applicable

Top of scale: 1

2012: 1 trials (Not applicable 1) 2014: 1 trials (Phase 4 1) 2018: 1 trials (Not applicable 1) 2022: 1 trials (Phase 1 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2022 1
2018 1
2014 1
2012 1

No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Korsakoff Syndrome trials in? (3)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 1
Phase 4 1
Not applicable 2

How many Korsakoff Syndrome trials are recruiting? (3)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Completed 2
Terminated 1
Unknown status 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Korsakoff Syndrome trials? (2)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Benfovir AG 1
MD Stem Cells 1

Which publications cover Korsakoff Syndrome? (10)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
The importance of thiamine (vitamin B1) in humans. Bioscience reports 2023 Yes
Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders. Internal medicine journal 2014 Yes
Wernicke's encephalopathy and Korsakoff's syndrome revisited. Neuropsychology review 2012 Yes
"Do you remember what you did on March 13, 1985?" A case study of confabulatory hypermnesia. Cortex; a journal devoted to the study of the nervous system and behavior 2009 Yes
Prevention and treatment of Wernicke-Korsakoff syndrome. Alcohol and alcoholism (Oxford, Oxfordshire). Supplement 2000 Yes

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages